{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:12:08Z","timestamp":1792588328272,"version":"4.5.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["kidney-international.theisn.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1038\/ki.2015.290","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T16:43:00Z","timestamp":1446655380000},"page":"135-146","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":447,"title":["Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production"],"prefix":"10.1016","volume":"89","author":[{"given":"Valentin","family":"David","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Isakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Spaulding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly B.","family":"Zumbrennen-Bullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia Chi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert Y.","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie L.","family":"Babitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myles","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2015.290_bib1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1152\/physrev.00002.2011","article-title":"Regulation and function of the FGF23\/ klotho endocrine pathways","volume":"92","author":"Martin","year":"2012","journal-title":"Physiol Rev"},{"key":"10.1038\/ki.2015.290_bib2","series-title":"Vitamin D","first-page":"747","article-title":"Chapter 42\u2014FGF23\/klotho new regulators of vitamin D metabolism","author":"David","year":"2011"},{"key":"10.1038\/ki.2015.290_bib3","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1038\/ki.2015.290_bib4","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1038\/ki.2015.290_bib5","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s00467-013-2515-7","article-title":"Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure","volume":"28","author":"Isakova","year":"2013","journal-title":"Pediatr Nephrol (Berlin, Germany)"},{"key":"10.1038\/ki.2015.290_bib6","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000353593","article-title":"The role of fibroblast growth factor-23 in cardiorenal syndrome","volume":"123","author":"Kovesdy","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"10.1038\/ki.2015.290_bib7","doi-asserted-by":"crossref","first-page":"e66182","DOI":"10.1371\/journal.pone.0066182","article-title":"Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver- transplant waiting list","volume":"8","author":"Prie","year":"2013","journal-title":"PLoS One"},{"key":"10.1038\/ki.2015.290_bib8","doi-asserted-by":"crossref","first-page":"e863","DOI":"10.1152\/ajpendo.00596.2012","article-title":"FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy","volume":"304","author":"Touchberry","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1038\/ki.2015.290_bib9","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1681\/ASN.2010080894","article-title":"Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality","volume":"22","author":"Wolf","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1038\/ki.2015.290_bib10","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J\u00a0Clin Invest"},{"key":"10.1038\/ki.2015.290_bib11","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1210\/me.2012-1062","article-title":"Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice","volume":"26","author":"Martin","year":"2012","journal-title":"Mol Endocrinol"},{"key":"10.1038\/ki.2015.290_bib12","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1096\/fj.10-177816","article-title":"Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling","volume":"25","author":"Martin","year":"2011","journal-title":"FASEB J"},{"key":"10.1038\/ki.2015.290_bib13","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","article-title":"Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism","volume":"38","author":"Feng","year":"2006","journal-title":"Nat Genet"},{"key":"10.1038\/ki.2015.290_bib14","doi-asserted-by":"crossref","first-page":"4469","DOI":"10.1210\/en.2013-1627","article-title":"Calcium regulates FGF-23 expression in bone","volume":"154","author":"David","year":"2013","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2015.290_bib15","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","article-title":"Fibroblast growth factor 23 is a counter- regulatory phosphaturic hormone for vitamin D","volume":"17","author":"Liu","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1038\/ki.2015.290_bib16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/ki.2011.107","article-title":"Direct and indirect effects of parathyroid hormone on circulating levels of fibroblast growth factor 23 in\u00a0vivo","volume":"80","author":"Lopez","year":"2011","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2015.290_bib17","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2015.290_bib18","doi-asserted-by":"crossref","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","article-title":"Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice","volume":"108","author":"Farrow","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2015.290_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jbmr.516","article-title":"Longitudinal evaluation of FGF23 changes and mineral metabolism abnormalities in a mouse model of chronic kidney disease","volume":"27","author":"Stubbs","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1038\/ki.2015.290_bib20","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1210\/jc.2009-1603","article-title":"Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active","volume":"95","author":"Shimada","year":"2010","journal-title":"J\u00a0Clin Endocrinol metab"},{"key":"10.1038\/ki.2015.290_bib21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2215\/CJN.01670408","article-title":"Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988\u20132004","volume":"4","author":"Fishbane","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2015.290_bib22","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1007\/s00198-009-1142-4","article-title":"Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease","volume":"21","author":"Manghat","year":"2010","journal-title":"Osteoporosis Int"},{"key":"10.1038\/ki.2015.290_bib23","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2215\/CJN.13281211","article-title":"Fibroblast growth factor 23 and Inflammation in CKD","volume":"7","author":"Munoz Mendoza","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2015.290_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jbmr.2049","article-title":"Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice","volume":"29","author":"Clinkenbeard","year":"2014","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1038\/ki.2015.290_bib25","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2009-09-245977","article-title":"Antihepcidin antibody treatment modulates iron metabolism and is effective in a mouse model of inflammation-induced anemia","volume":"115","author":"Sasu","year":"2010","journal-title":"Blood"},{"key":"10.1038\/ki.2015.290_bib26","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1182\/blood-2013-08-521419","article-title":"A\u00a0mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin","volume":"123","author":"Kim","year":"2014","journal-title":"Blood"},{"key":"10.1038\/ki.2015.290_bib27","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/ki.2008.299","article-title":"Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"74","author":"Locatelli","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2015.290_bib28","first-page":"S11","article-title":"KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease","volume":"47","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2015.290_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-386960-9.00001-0","article-title":"Vitamin D regulation of immune function","volume":"86","author":"Bikle","year":"2011","journal-title":"Vitam Horm"},{"key":"10.1038\/ki.2015.290_bib30","doi-asserted-by":"crossref","first-page":"5968","DOI":"10.4049\/jimmunol.1003332","article-title":"Vitamin D and the regulation of placental inflammation","volume":"186","author":"Liu","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1038\/ki.2015.290_bib31","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1939-1676.2005.tb02686.x","article-title":"Alterations in serum parathyroid hormone and electrolyte concentrations and urinary excretion of electrolytes in horses with induced endotoxemia","volume":"19","author":"Toribio","year":"2005","journal-title":"J\u00a0Vet Intern Med"},{"key":"10.1038\/ki.2015.290_bib32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1677\/JOE-08-0568","article-title":"Bone loss in inflammatory disorders","volume":"201","author":"Hardy","year":"2009","journal-title":"J\u00a0Endocrinol"},{"key":"10.1038\/ki.2015.290_bib33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00007890-199701150-00026","article-title":"Interleukin 1 receptor blockade reduces tumor necrosis factor production, tissue injury, and mortality after hepatic ischemia-reperfusion in the rat","volume":"63","author":"Shito","year":"1997","journal-title":"Transplantation"},{"key":"10.1038\/ki.2015.290_bib34","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1172\/JCI113812","article-title":"Interleukin 1 administration in mice produces hypoferremia despite neutropenia","volume":"82","author":"Gordeuk","year":"1988","journal-title":"J\u00a0Clin Invest"},{"key":"10.1038\/ki.2015.290_bib35","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.ajkd.2009.12.030","article-title":"Molecular mechanisms of hepcidin regulation: implications for the anemia of CKD","volume":"55","author":"Babitt","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/ki.2015.290_bib36","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1681\/ASN.2011111078","article-title":"Mechanisms of anemia in CKD","volume":"23","author":"Babitt","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1038\/ki.2015.290_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/1871530311313020001","article-title":"Decreased parathyroid hormone levels despite persistent hypocalcemia in patients with kidney failure recovering from septic shock","volume":"13","author":"Pinheiro da Silva","year":"2013","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1038\/ki.2015.290_bib38","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2265.1990.tb00873.x","article-title":"Impaired secretion of parathyroid hormone in patients with rheumatoid arthritis: relationship to inflammatory activity","volume":"32","author":"af Ekenstam","year":"1990","journal-title":"Clin Endocrinol"},{"key":"10.1038\/ki.2015.290_bib39","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1172\/JCI28550","article-title":"Estrogen deficiency and bone loss: an inflammatory tale","volume":"116","author":"Weitzmann","year":"2006","journal-title":"J\u00a0Clin Invest"},{"key":"10.1038\/ki.2015.290_bib40","doi-asserted-by":"crossref","first-page":"e40738","DOI":"10.1371\/journal.pone.0040738","article-title":"Furin overexpression suppresses tumor growth and predicts a better postoperative disease-free survival in hepatocellular carcinoma","volume":"7","author":"Huang","year":"2012","journal-title":"PLoS One"},{"key":"10.1038\/ki.2015.290_bib41","doi-asserted-by":"crossref","first-page":"e44161","DOI":"10.1371\/journal.pone.0044161","article-title":"A\u00a0comparative transcriptome analysis identifying FGF23 regulated genes in the kidney of a mouse CKD model","volume":"7","author":"Dai","year":"2012","journal-title":"PLoS One"},{"issue":"Pt 1","key":"10.1038\/ki.2015.290_bib42","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1042\/bj3500307","article-title":"Interleukin 1 induces hypoxia- inducible factor 1 in human gingival and synovial fibroblasts","volume":"350","author":"Thornton","year":"2000","journal-title":"Biochem J"},{"key":"10.1038\/ki.2015.290_bib43","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1196\/annals.1422.035","article-title":"Regulation of cytokine-induced HIF-1alpha expression in rheumatoid synovial fibroblasts","volume":"1108","author":"Westra","year":"2007","journal-title":"Ann NY Acad Sci"},{"key":"10.1038\/ki.2015.290_bib44","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1002\/jbmr.1546","article-title":"Mechanism of FGF23 processing in fibrous dysplasia","volume":"27","author":"Bhattacharyya","year":"2012","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1038\/ki.2015.290_bib45","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/jbmr.1923","article-title":"Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women","volume":"28","author":"Wolf","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1038\/ki.2015.290_bib46","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/ki.2013.526","article-title":"Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease","volume":"85","author":"Spichtig","year":"2014","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2015.290_bib47","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/ng1358","article-title":"Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis","volume":"36","author":"Topaz","year":"2004","journal-title":"Nat Genet"},{"key":"10.1038\/ki.2015.290_bib48","doi-asserted-by":"crossref","first-page":"18370","DOI":"10.1074\/jbc.M602469200","article-title":"Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation","volume":"281","author":"Kato","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1038\/ki.2015.290_bib49","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1172\/JCI31370","article-title":"Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs)","volume":"117","author":"Peyssonnaux","year":"2007","journal-title":"J\u00a0Clin Invest"},{"key":"10.1038\/ki.2015.290_bib50","first-page":"1764","article-title":"Effect of ascorbate on the activity\u00a0of hypoxia-inducible factor in cancer cells","volume":"63","author":"Knowles","year":"2003","journal-title":"Cancer Res"},{"key":"10.1038\/ki.2015.290_bib51","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jbmr.2049","article-title":"Neonatal iron deficiency causes abnormal phosphate metabolism by elevating FGF23 in normal and ADHR mice","volume":"29","author":"Clinkenbeard","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1038\/ki.2015.290_bib52","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1073\/pnas.0902006107","article-title":"Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23\u2013FGFR\u2013Klotho complex formation","volume":"107","author":"Goetz","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2015.290_bib53","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1128\/MCB.02249-06","article-title":"Molecular insights into the klotho- dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members","volume":"27","author":"Goetz","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1038\/ki.2015.290_bib54","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/ki.2013.150","article-title":"Plasma FGF23 levels increase rapidly after acute kidney injury","volume":"84","author":"Christov","year":"2013","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2015.290_bib55","first-page":"167","article-title":"Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia","volume":"46","author":"Schouten","year":"2009","journal-title":"Ann\u00a0Clin Biochem"},{"key":"10.1038\/ki.2015.290_bib56","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1210\/jc.2008-2396","article-title":"FGF23 elevation and hypophosphatemia after intravenous iron polymaltose: a prospective study","volume":"94","author":"Schouten","year":"2009","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1038\/ki.2015.290_bib57","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.bone.2009.06.017","article-title":"Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia","volume":"45","author":"Shimizu","year":"2009","journal-title":"Bone"},{"key":"10.1038\/ki.2015.290_bib58","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000327019","article-title":"Effect of intravenous saccharated ferric oxide on serum FGF23 and mineral metabolism in hemodialysis patients","volume":"33","author":"Takeda","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1038\/ki.2015.290_bib59","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1210\/en.2009-0216","article-title":"Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator","volume":"150","author":"David","year":"2009","journal-title":"Endocrinology"},{"key":"10.1038\/ki.2015.290_bib60","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1210\/en.2007-1205","article-title":"Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP","volume":"149","author":"Martin","year":"2008","journal-title":"Endocrinology"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815000289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815000289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T01:59:15Z","timestamp":1577843955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815000289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0085253815000289"],"URL":"https:\/\/doi.org\/10.1038\/ki.2015.290","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation and functional iron deficiency regulate fibroblast growth factor 23 production","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/ki.2015.290","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}